Combined Lipoxygenase/Cyclo-oxygenase Inhibition in the Elderly: The Example of Licofelone

ISSN： 1170-229X

Source： Drugs & Aging, Vol.22, Iss.5, 2005-01, pp. : 393-403

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of cyclo-oxygenase and lipoxygenase reviewed

Inpharma, Vol. 1, Iss. 1317, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase

By Rioja I. Terencio M.C. Ubeda A. Molina P. Tarraga A. Gonzalez-Tejero A. Alcaraz M.J.

European Journal of Pharmacology, Vol. 434, Iss. 3, 2002-01 ,pp. : 177-185

Elsevier

Access to resources Recommend Favorite

Licofelone, a dual lipoxygenase-cyclooxygenase inhibitor, downregulates polymorphonuclear leukocyte and platelet function

By Rotondo S. Dell'Elba G. Krauze-Brzosko K. Manarini S. Martelli N. Pecce R. Evangelista V. Cerletti C.

European Journal of Pharmacology, Vol. 453, Iss. 1, 2002-10 ,pp. : 131-139

Elsevier

Access to resources Recommend Favorite

Cyclo-Oxygenase-2 and its Inhibition in Cancer: Is There a Role?

By Liao Zhongxing

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 821-845

Adis International

Access to resources Recommend Favorite

The pharmacological profile of ML3000: A new pyrrolizine derivative inhibiting the enzymes cyclo-oxygenase and 5-lipoxygenase

By Tries S.

Inflammopharmacology, Vol. 9, Iss. 1-2, 2001-05 ,pp. : 113-124

VSP

Access to resources Recommend Favorite